Literature DB >> 31934554

A Novel G385E Variant in the Cold Region of the T3-Binding Domain of Thyroid Hormone Receptor Beta Gene and Investigations to Assess Its Clinical Significance.

Manassawee Korwutthikulrangsri1,2, Chrysoula Dosiou3, Alexandra M Dumitrescu1,4, Samuel Refetoff1,5,6.   

Abstract

BACKGROUND: Resistance to thyroid hormone beta (RTHβ) is characterized by elevated thyroid hormone and unsuppressed thyroid-stimulating hormone (TSH), caused by thyroid hormone receptor beta gene (THRB) defects. Most mutations producing RTHβ phenotype are located in CG-rich regions of THRB, encoding the T3-binding and hinge domains of the receptor. However, a region encompassing codons 384-425 is virtually devoid of RTHβ-causing mutations, termed "cold region." CASE: A 49-year-old woman was diagnosed with Hashimoto thyroiditis in her twenties, and levothyroxine (LT4) was initiated. During LT4 treatment she had slightly elevated free thyroxine and TSH levels, suggesting the possibility of RTHβ.
RESULTS: Sequencing of THRB identified a heterozygous missense variant c.1154G>A producing p.G385E in the proband. Since this variant of unknown significance (VUS) has not been reported in RTHβ individuals and considering its location in the "cold region" of THRB, we questioned its relevance. In silico functional prediction algorithms showed conflicting results: PolyPhen-2 predicted this VUS to be probably damaging with a score of 1.000, while SIFT predicted it to be tolerated with a score of 0.07, thus making additional investigations necessary. Genotyping of family members revealed that the proband's mother and sister, without RTHβ phenotype, also harbored the same variant. This indicates that the THRB G385E variant is unlikely to manifest RTHβ phenotype and confirms its "cold" status.
CONCLUSIONS: This study illustrates that assigning causality of a THRB VUS for RTHβ based only on in silico prediction algorithms is not always fully reliable. Additional phenotype-genotype segregation in family members can assist in predicting functional consequences of missense mutations.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Cold region; Resistance to thyroid hormone beta; Thyroid hormone receptor beta gene

Year:  2019        PMID: 31934554      PMCID: PMC6944928          DOI: 10.1159/000503860

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  14 in total

1.  A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.

Authors:  R J Clifton-Bligh; F de Zegher; R L Wagner; T N Collingwood; I Francois; M Van Helvoirt; R J Fletterick; V K Chatterjee
Journal:  Mol Endocrinol       Date:  1998-05

2.  Incidental identification of a thyroid hormone receptor beta (THRB) gene variant in a family with autoimmune thyroid disease.

Authors:  Cæcilie C Larsen; Alexandra Dumitrescu; Laura M Guerra-Argüero; Cecillia Gállego-Suárez; Alberto Vazquez-Mellado; Maia Vinogradova; Robert Fletterick; Samuel Refetoff; Roy E Weiss
Journal:  Thyroid       Date:  2013-09-13       Impact factor: 6.568

3.  T426I a new mutation in the thyroid hormone receptor beta gene in a sporadic patient with resistance to thyroid hormone and dysmorphism. Mutations in brief no. 192. Online.

Authors:  C Menzaghi; R Di Paola; A Corrias; S Einaudi; V Trischitta; C De Sanctis; V De Filippis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone.

Authors:  J D Safer; M G O'Connor; S D Colan; S Srinivasan; S R Tollin; F E Wondisford
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

Review 5.  Age- and race-based serum thyrotropin reference limits.

Authors:  Martin I Surks; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

6.  Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.

Authors:  Massimo Torlontano; Cosimo Durante; Isabella Torrente; Umberto Crocetti; Giovanni Augello; Giuseppe Ronga; Teresa Montesano; Laura Travascio; Antonella Verrienti; Rocco Bruno; Stefano Santini; Palmina D'Arcangelo; Bruno Dallapiccola; Sebastiano Filetti; Vincenzo Trischitta
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

7.  Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Authors:  Y Hayashi; T Sunthornthepvarakul; S Refetoff
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.

Authors:  Damiano Gullo; Adele Latina; Francesco Frasca; Rosario Le Moli; Gabriella Pellegriti; Riccardo Vigneri
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

9.  SIFT web server: predicting effects of amino acid substitutions on proteins.

Authors:  Ngak-Leng Sim; Prateek Kumar; Jing Hu; Steven Henikoff; Georg Schneider; Pauline C Ng
Journal:  Nucleic Acids Res       Date:  2012-06-11       Impact factor: 16.971

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  3 in total

1.  Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the THRB Gene Causing Resistance to Thyroid Hormone Syndrome.

Authors:  Irene Campi; Maura Agostini; Federica Marelli; Tiziana de Filippis; Beatriz Romartinez-Alonso; Odelia Rajanayagam; Giuditta Rurale; Ilaria Gentile; Federica Spagnolo; Massimiliano Andreasi; Francesco Ferraù; Salvatore Cannavò; Laura Fugazzola; Krishna V Chatterjee; Luca Persani
Journal:  Eur Thyroid J       Date:  2021-10-22

Review 2.  Resistance to Thyroid Hormone Beta: A Focused Review.

Authors:  Theodora Pappa; Samuel Refetoff
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

3.  Thyroid hormone resistance syndrome due to a novel heterozygous mutation and concomitant Hashimoto's Thyroiditis: A pedigree report.

Authors:  Zongyan Xie; ChenFei Li; Yaxin An; Dong Zhao; Xuhong Wang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.